MetaCap

Intelligent Bio Solutions Insider Trades

NASDAQ: INBSHealth CareMedical/Dental InstrumentsUSD

1.53-0.04 (-2.55%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
0 · $0
Sales
0 · $0
Shares bought / sold
0 / 0
Net activity
Net buying $0

Intelligent Bio Solutions insider activity

Over the last 12 months, Intelligent Bio Solutions insiders reported 8 transactions on SEC Form 4: 0 open-market purchases and 0 sales. The most recent filing shows Boyages Steven Constantine (Director) reporting a transaction in 5,000 shares on Mar 18, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put INBS's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

INBS insider transactions

Intelligent Bio Solutions insider transactions
DateInsiderTypeSharesValueFiling
Mar 18, 2026Isenberg JasonDirectorAward5,000—Form 4
Mar 18, 2026Hurd Jonathan ScottDirectorAward5,000—Form 4
Mar 18, 2026Sakiris Spiro KevinChief Financial OfficerAward21,350—Form 4
Mar 18, 2026Sakiris Spiro KevinChief Financial OfficerAward9,150—Form 4
Mar 18, 2026Simeonidis HarryChief Executive OfficerAward21,350—Form 4
Mar 18, 2026Simeonidis HarryChief Executive OfficerAward9,150—Form 4
Mar 18, 2026Fraser Nicola MarionDirectorAward5,000—Form 4
Mar 18, 2026Boyages Steven ConstantineDirectorAward5,000—Form 4
Sep 25, 2024Simeonidis HarryChief Executive OfficerAward40,000—Form 4
Sep 25, 2024Sakiris Spiro KevinChief Financial OfficerAward34,500—Form 4
Sep 25, 2024Sakiris Spiro KevinChief Financial OfficerAward34,500—Form 4
Mar 20, 2024Sakiris Spiro KevinChief Financial OfficerOption exercise9,394—Form 4
Oct 4, 2023Sakiris Spiro KevinChief Financial OfficerBuy112,727—Form 4
Oct 4, 2023TOWERS CHRISTOPHERDirectorBuy9,090—Form 4
Sep 1, 2023Simeonidis HarryCEOBuy50$92.50Form 4
Aug 31, 2023Simeonidis HarryCEOBuy100$192Form 4
May 10, 2023Sakiris Spiro KevinChief Financial OfficerConversion2,399$13.91KForm 4
Oct 10, 2022Sakiris Spiro KevinChief Financial OfficerAward75,000—Form 4
Oct 10, 2022Boyages Steven ConstantineInterim CEO and ChairpersonAward75,000—Form 4
Oct 10, 2022FISHER LAWRENCE BDirectorAward15,000—Form 4
Oct 10, 2022TOWERS CHRISTOPHERDirectorAward15,000—Form 4
Oct 10, 2022Hurd Jonathan ScottDirectorAward15,000—Form 4
Oct 10, 2022Simeonidis HarryPresidentAward80,000—Form 4
Oct 10, 2022Margelis GeorgeDirectorAward15,000—Form 4
Jun 22, 2022Sakiris Spiro KevinChief Financial OfficerBuy5,000$3.25KForm 4
Jun 17, 2022Sakiris Spiro KevinChiefFinancial OfficerBuy15,970$9.77KForm 4
Feb 17, 2022Life Science Biosensor Diagnostics Pty LtdFormer 10% ownerSale576,028$293.77KForm 4
Feb 16, 2022Life Science Biosensor Diagnostics Pty Ltd10% OwnerSale100,000$63.00KForm 4
Feb 15, 2022Life Science Biosensor Diagnostics Pty Ltd10% OwnerSale100,000$68.00KForm 4
Feb 14, 2022Life Science Biosensor Diagnostics Pty Ltd10% OwnerSale100,000$70.00KForm 4
Feb 11, 2022Life Science Biosensor Diagnostics Pty Ltd10% OwnerSale100,000$75.00KForm 4
Feb 10, 2022Life Science Biosensor Diagnostics Pty Ltd10% OwnerSale100,000$84.00KForm 4
Feb 9, 2022Life Science Biosensor Diagnostics Pty Ltd10% OwnerSale100,000$86.00KForm 4
Feb 8, 2022Life Science Biosensor Diagnostics Pty Ltd10% OwnerSale100,000$89.00KForm 4
Feb 2, 2022Life Science Biosensor Diagnostics Pty Ltd10% OwnerSale100,000$92.00KForm 4
Jan 31, 2022Life Science Biosensor Diagnostics Pty Ltd10% OwnerSale100,000$90.00KForm 4
Jan 28, 2022Life Science Biosensor Diagnostics Pty Ltd10% OwnerSale100,000$92.00KForm 4
Jan 27, 2022Life Science Biosensor Diagnostics Pty Ltd10% OwnerSale100,000$100.00KForm 4
Dec 30, 2021Parmakellis TomDirectorBuy4,500$6.97KForm 4
Dec 17, 2021Life Science Biosensor Diagnostics Pty Ltd10% OwnerSale200,000$298.00KForm 4
Dec 16, 2021Parmakellis TomDirectorBuy2,800$4.73KForm 4
Dec 6, 2021Sakiris Spiro KevinChiefFinancial OfficerBuy10,000$17.00KForm 4
Nov 30, 2021Life Science Biosensor Diagnostics Pty Ltd10% OwnerSale250,000$467.50KForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related